JANX

Janux Therapeutics (JANX)

About Janux Therapeutics (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

Details

Daily high
$37.90
Daily low
$36.17
Price at open
$37.07
52 Week High
$71.71
52 Week Low
$8.28
Market cap
2.1B
Dividend yield
0.00%
Volume
605,425
Avg. volume
978,621
P/E ratio
-31.61

Janux Therapeutics News

Details

Daily high
$37.90
Daily low
$36.17
Price at open
$37.07
52 Week High
$71.71
52 Week Low
$8.28
Market cap
2.1B
Dividend yield
0.00%
Volume
605,425
Avg. volume
978,621
P/E ratio
-31.61